Villarreal Garza, CynthiaLopez Martinez, Edna AnakarennDeneken Hernandez, ZuratziMaffuz Aziz, AntonioMuñoz Lozano, Jose FelipeBarragan Carrillo, ReginaRamos Elias, PierMoreno, BrizioDiaz Perez, HectorPeña Curiel, OmarCuriel Valdez, Jose de JesusBautista Piña, Veronica2022-06-292022-06-292020-03-11Villarreal-Garza C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, Muñoz-Lozano JF, Barragan-Carrillo R, et al. (2020) Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients. PLoS ONE 15(3): e0228884. https://doi.org/10.1371/journal.pone.0228884https://doi.org/10.1371/journal.pone.0228884https://hdl.handle.net/11285/648507To evaluate the change in adjuvant therapeutic decision in a cohort of young women with breast cancer discussed by a multidisciplinary team, before and after EndoPredict testing.TextoengopenAccesshttp://creativecommons.org/licenses/by/4.0MEDICINA Y CIENCIAS DE LA SALUD::CIENCIAS MÉDICAS::CIENCIAS CLÍNICAS::ONCOLOGÍAMedicineArtículoPLoS ONECancer treatmentBreast cancerCancers and neoplasmsCancer chemotherapyEndocrine therapyOncologyCancer risk factorsDecision making153Estados Unidos de América / United States